Developer docs
API playgroundTry for free, no card

Search company profiles

Rainwater Charitable Foundation

Full company profile

uuid0009o6p

Namestring
Rainwater Charitable Foundation
Legal namestring
Rainwater Charitable Foundation
Company typeenum
Private
Founded yearint
1991
Descriptiontext

The Rainwater Charitable Foundation (RCF) is a private family foundation based in Fort Worth, Texas, established in 1991 by private-equity investor Richard E. Rainwater and operating as a 501(c)(3) nonprofit under Texas law. RCF is a grant-making entity, not a commercial enterprise: it deploys capital from its endowment across three program areas — Family Economic Security (K-12 education, upskilling, affordable housing, childcare for North Texas families), Medical Research (focused on primary tauopathies such as PSP, CBD, Pick's disease, and FTD), and Other Foundation Programs (scholarships, East Africa education, EdTech, cultural access). Since 2012 it has deployed over $426M in total, split across Family Economic Security ($240.3M+), Medical Research ($166.7M+), and Other Foundation Funding ($103.9M+), and has supported 500+ organizations globally. The organization runs on 11-50 employees.

RCF's medical research work is its most sophisticated and structured area, built around the Tau Consortium (a collaborative research and drug-discovery network), the Rainwater Prize program (awards from $200K up to a $10M Breakthrough Prize for PSP treatments), the Tauopathy Challenge Workshop (grants up to $500K over two years), and the Sprint-to-Lead drug discovery grants (up to $400K). It underwrites shared research infrastructure — including one of the world's largest tauopathy brain banks (11,000+ samples at Mayo Clinic Florida), a Bioinformatics Hub, and a Human iPSC line collection — and coordinates biorepository access through partners such as ALLFTD, NCRAD, and BioSEND. The foundation reports 8 treatments advanced into human trials through its support. The medical thesis treats primary tauopathies as "pathfinder diseases" whose insights may transfer to more common conditions like Alzheimer's.

RCF has no conventional revenue model; it does not sell products or generally accept individual donations, funding activity instead through its endowment and program-related investments (e.g., an EQ2 investment in CDFI Capital Good Fund and gap financing for the Maren Grove affordable-housing project). Grants are distributed via competitive, invitation-only, and LOI-based processes managed through a Grantee Portal, and the foundation extends its reach through co-funding partnerships with the Alzheimer's Association, CurePSP, Aging Mind Foundation, Michael J. Fox Foundation, and FNIH. Leadership includes President Jeremy Smith, EVP/CFO Melissa Parrish, and CIO Aaron Bigbee. Following the May 2026 death of long-serving trustee Walter Rainwater, RCF is in a transition period during which the Letter of Inquiry process has been temporarily paused pending a recalibration of funding priorities.

Short descriptiontext

Rainwater Charitable Foundation is a Fort Worth-based private family foundation, founded 1991, making grants across North Texas family economic security, primary-tauopathy medical research, and education programs, having deployed over $426M to 500+ organizations globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFort Worth, United States
HQ citystring
Fort Worth
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
philanthropic grantmaking, neurodegenerative research funding, tauopathy research grants, family foundation giving, community education grants
Industry3 codes
PRIMARYBPAGAKAB
Community Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAK
Education Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Social Services8300
Product category
Philanthropic Foundation
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Others, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Tau Consortium
Description

A collaborative research program managed and funded by RCF that commissions world-class research and drug discovery programs to treat and prevent primary tauopathies.

rainwatercharitablefoundation.org
+3 more records
Core offering1 text field

The Rainwater Charitable Foundation is a private family foundation that makes grants across three program areas: Medical Research (funding tauopathy and neurodegenerative disease research through the Tau Consortium, Rainwater Prize, Tauopathy Challenge Workshop, and Sprint to Lead Drug Discovery grants); Family Economic Security (supporting North Texas families through quality education, upskilling, affordable housing, and childcare); and Other Foundation Programs (Africa education initiatives and scholarships). It also operates program-related investments and a Grantee Portal for grant management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 8 treatments advanced into human trials through RCF medical research support
+6 more records
Product overview1 text field

The Rainwater Charitable Foundation (RCF) is a private family foundation with three primary program areas: Family Economic Security, Medical Research, and Other Foundation Programs. The Medical Research Program is the most technology-focused, comprising the Tau Consortium (collaborative research network), the Rainwater Prize (award program), the Tauopathy Challenge Workshop (funding initiative), and the Sprint to Lead Drug Discovery Grant. RCF also provides research infrastructure including the Tau Consortium Bioinformatics Hub and Human iPSC Line Collection for the scientific community. The Foundation does not operate as a unified software platform but rather as a collection of grant-making programs and research resources.

Product and service9 records
1Tau Consortium
CategoryMedical Research Funding Program
Description

Collaborative research program funded and managed by RCF that commissions world-class research and drug discovery programs to treat and prevent primary tauopathies. It fosters high-impact networks of scientists to better understand tauopathies and guide development of effective treatments.

2Rainwater Prize
CategoryMedical Research Award Program
Description

Award program recognizing scientific progress toward new treatments for neurodegenerative diseases associated with tau protein accumulation. Includes Outstanding Innovation in Neurodegenerative Research ($400K), Innovative Early-Career Scientists ($200K), Milestone Prize for Advances in Tauopathy Research (up to $2M), and Breakthrough Prize for Effective Treatments in PSP ($2M-$10M).

3Tauopathy Challenge Workshop
CategoryMedical Research Funding Program
Description

A funding program established in 2023 that convenes interdisciplinary experts around a single topic to address unmet needs in primary tauopathies. Provides up to $500,000 in direct costs over two years for research grants, with up to four awards funded annually.

4Sprint to Lead (S2L) Drug Discovery Grant Program
CategoryMedical Research Drug Discovery Grant
Description

Grant program inviting original ideas focused exclusively on accelerating the development of therapies for primary tauopathies within the hit-to-lead and lead optimization development phases of drug discovery. Awards up to $400,000 direct costs for one year.

5Tau Consortium Bioinformatics Hub
CategoryResearch Data Platform
Description

Centralized platform providing researchers with high-quality computational tools, curated multi-omics datasets, analytical pipelines, and bioinformatics training resources to advance the study of tau biology and neurodegenerative disease.

6Tau Consortium Human iPSC Line Collection
CategoryResearch Resource Repository
Description

A rigorously characterized repository of induced pluripotent stem cell (iPSC) lines derived from donors with tauopathy-linked mutations as well as matched controls, hosted via the Neural Stem Cell Institute.

7Family Economic Security Program
CategoryCommunity Grant Program
Description

RCF program committed to supporting North Texas families and children through quality education, upskilling, affordable housing, and childcare. Includes Early Childhood & Family Support, K-12 Education, Upskilling, and Community Asset Building funding areas.

8Grantee Portal
CategoryGrant Management Web Portal
Description

Online portal for grant recipients to manage their grants and reporting.

9DASH Pass Program
CategoryCommunity Access Program
Description

A card that provides free access to museums, theaters, and cultural institutions across Fort Worth for families, aiming to reduce barriers to enriching experiences for children.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
1Aging Mind Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-13
Description

Co-funding partner for the Tauopathy Challenge Workshop, contributing to $2.5 million in grants for five neurodegenerative disease research projects in 2025. The partnership aims to support novel, mechanism-focused research for primary tauopathies.

prnewswire.com
2Alzheimer's Association
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-13
Description

Collaborative partner in the Tauopathy Challenge Workshop, co-funding grants for neurodegenerative disease research. Also partner in The Tau Pipeline Enabling Program (T-PEP). Host of Tau Global Conference with RCF.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-13
Description

Co-funding partner for the Tauopathy Challenge Workshop and multiple joint initiatives including the Biomarker Accelerator Program, Pathway and Pipeline Grant Program, Prime of Life Brain Initiative, and PSP Genetics Consortium. Co-host of Tau Global Conference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in the Biomarkers Consortium for Neurofilament as a Blood-Based Biomarker of Neurodegeneration in FTD.

5The Association for Frontotemporal Degeneration (AFTD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in the FTD Diagnostic Biomarkers Initiative to advance diagnostic capabilities for frontotemporal degenerations.

rainwatercharitablefoundation.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Registry connecting patients with clinical trials and research studies for FTD and related conditions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the Neurofilament Light Surveillance Project (NSP) for neurodegenerative disease research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in Philanthropic Investments in PET Tracers (PIPETTE) for 4R tau and alpha-synuclein PET tracer development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnered with RCF to map the biorepository landscape for primary tauopathies, developing a searchable database and identifying bottlenecks in sample access.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home to one of the world's largest tauopathy brain banks (11,000+ samples) led by Rainwater Prize winners Drs. Dickson and Murray. Key research partner in tauopathy neuropathology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Development partner for the 90-unit Maren Grove affordable housing property in South Fort Worth, where RCF provided gap financing through subordinate, concessionary debt.

12ALLFTD (ARTFL LEFFTDS Longitudinal FTLD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RCF provides access to ALLFTD biospecimens and data through its tauopathy resources page, including genomic DNA, RNA, plasma, serum, PBMCs and CSF samples.

rainwatercharitablefoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RCF provides access to NCRAD biospecimens and coordinates for researchers through its primary tauopathy resources page.

14BioSEND (Biospecimen Exchange for Neurological Disorders)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RCF directs researchers to BioSEND for broader neurodegenerative disease cohorts including primary tauopathies and non-tauopathies.

rainwatercharitablefoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hosts the Tau Consortium Human iPSC Line Collection providing patient-derived stem cell lines for tauopathy research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

RCF references NIH NeuroBioBank as an example of coordinated biorepository infrastructure for post-mortem brain tissue access.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community development financial institution that RCF mentions as potential PRI partner for managed funds focusing on affordable housing and small business capital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home institution of 2026 Rainwater Prize winner Dr. Marc Aurel Busche, conducting research on soluble tau species and neuronal dysfunction.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated institution of 2026 Rainwater Prize winner Dr. Marc Aurel Busche, supporting research on tau-related dementia mechanisms.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Alzheimer's Association
TypeBroad incumbent
Description

Largest nonprofit funder of Alzheimer's disease research and a core RCF partner in the Tauopathy Challenge Workshop and Tau Global Conference. Both organizations fund neurodegenerative research and engage with overlapping scientific and patient communities.

TypeDirect peer
Description

Nonprofit focused specifically on PSP, CBD, and other prime of life neurodegenerative diseases, co-funding multiple RCF initiatives including the Biomarker Accelerator Program and PSP Genetics Consortium. Most direct peer given overlapping focus on primary tauopathies.

TypeDirect peer
Description

Leading nonprofit funder of Parkinson's disease research with an analogous venture philanthropy model, including milestone-driven grants and PET tracer development. RCF partner in the PIPETTE initiative for tau and alpha-synuclein tracers.

TypeDirect peer
Description

Nonprofit focused on FTD research, partnering with RCF on the Neurofilament Light Surveillance Project. Direct peer given shared focus on frontotemporal degeneration and tau-related disease research.

TypeDirect peer
Description

Nonprofit that funds research on Alzheimer's, macular degeneration, and glaucoma through grants to investigators. Comparable grantmaking model and neurodegenerative disease focus with similar scale and approach to research funding.

TypeDirect peer
Description

Major nonprofit funder of amyotrophic lateral sclerosis research, with a similar venture philanthropy model including drug discovery funding and clinical trial support. Comparable approach to accelerating neurodegenerative disease treatments.

TypeEmerging player
Description

Family-founded nonprofit focused on Huntington's disease and other hereditary neurodegenerative disorders. Comparable in scale, founding model (family foundation), and focus on rare neurological disease research.

TypeBroad incumbent
Description

Large private family foundation with significant medical research funding alongside arts, environment, and child welfare programs. Structurally similar as a multi-program family foundation with comparable scale and grantmaking approach.

9Howard Hughes Medical Institute
TypeBroad incumbent
Description

Major biomedical research organization funding investigator-initiated research through HHMI investigators. Comparable as a substantial private medical research funder with research infrastructure investments and scientific talent development.

TypeEmerging player
Description

Nonprofit focused on accelerating ALS drug development through collaborative funding models. Comparable venture philanthropy approach with milestone-driven grants and research consortia, though focused on a different neurodegenerative disease.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rainwater Charitable Foundation

Philanthropic Foundationrainwatercharitablefoundation.org

Rainwater Charitable Foundation is a Fort Worth-based private family foundation, founded 1991, making grants across North Texas family economic security, primary-tauopathy medical research, and education programs, having deployed over $426M to 500+ organizations globally.

What Rainwater Charitable Foundation does

The Rainwater Charitable Foundation (RCF) is a private family foundation based in Fort Worth, Texas, established in 1991 by private-equity investor Richard E. Rainwater and operating as a 501(c)(3) nonprofit under Texas law. RCF is a grant-making entity, not a commercial enterprise: it deploys capital from its endowment across three program areas — Family Economic Security (K-12 education, upskilling, affordable housing, childcare for North Texas families), Medical Research (focused on primary tauopathies such as PSP, CBD, Pick's disease, and FTD), and Other Foundation Programs (scholarships, East Africa education, EdTech, cultural access). Since 2012 it has deployed over $426M in total, split across Family Economic Security ($240.3M+), Medical Research ($166.7M+), and Other Foundation Funding ($103.9M+), and has supported 500+ organizations globally. The organization runs on 11-50 employees.

RCF's medical research work is its most sophisticated and structured area, built around the Tau Consortium (a collaborative research and drug-discovery network), the Rainwater Prize program (awards from $200K up to a $10M Breakthrough Prize for PSP treatments), the Tauopathy Challenge Workshop (grants up to $500K over two years), and the Sprint-to-Lead drug discovery grants (up to $400K). It underwrites shared research infrastructure — including one of the world's largest tauopathy brain banks (11,000+ samples at Mayo Clinic Florida), a Bioinformatics Hub, and a Human iPSC line collection — and coordinates biorepository access through partners such as ALLFTD, NCRAD, and BioSEND. The foundation reports 8 treatments advanced into human trials through its support. The medical thesis treats primary tauopathies as "pathfinder diseases" whose insights may transfer to more common conditions like Alzheimer's.

RCF has no conventional revenue model; it does not sell products or generally accept individual donations, funding activity instead through its endowment and program-related investments (e.g., an EQ2 investment in CDFI Capital Good Fund and gap financing for the Maren Grove affordable-housing project). Grants are distributed via competitive, invitation-only, and LOI-based processes managed through a Grantee Portal, and the foundation extends its reach through co-funding partnerships with the Alzheimer's Association, CurePSP, Aging Mind Foundation, Michael J. Fox Foundation, and FNIH. Leadership includes President Jeremy Smith, EVP/CFO Melissa Parrish, and CIO Aaron Bigbee. Following the May 2026 death of long-serving trustee Walter Rainwater, RCF is in a transition period during which the Letter of Inquiry process has been temporarily paused pending a recalibration of funding priorities.

Rainwater Charitable Foundation firmographics

Firmographics
Name
Rainwater Charitable Foundation
Legal name
Rainwater Charitable Foundation
Website
https://rainwatercharitablefoundation.org
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
Rainwater Charitable Foundation is a Fort Worth-based private family foundation, founded 1991, making grants across North Texas family economic security, primary-tauopathy medical research, and education programs, having deployed over $426M to 500+ organizations globally.
Ownership category
akta.pro rank

Rainwater Charitable Foundation industry classification

Industry
Product category
Philanthropic Foundation
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGAKAB
Community Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAK
Education Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Philanthropic grantmaking
  • Neurodegenerative research funding
  • Tauopathy research grants
  • Family foundation giving
  • Community education grants

Where Rainwater Charitable Foundation is headquartered

Location

Headquarters

HQ city
Fort Worth
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rainwater Charitable Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Operations

Distribution channels4 records

Marketing channels9 records

Rainwater Charitable Foundation product offering

Product offering

Core offering

The Rainwater Charitable Foundation is a private family foundation that makes grants across three program areas: Medical Research (funding tauopathy and neurodegenerative disease research through the Tau Consortium, Rainwater Prize, Tauopathy Challenge Workshop, and Sprint to Lead Drug Discovery grants); Family Economic Security (supporting North Texas families through quality education, upskilling, affordable housing, and childcare); and Other Foundation Programs (Africa education initiatives and scholarships). It also operates program-related investments and a Grantee Portal for grant management.

Product overview

The Rainwater Charitable Foundation (RCF) is a private family foundation with three primary program areas: Family Economic Security, Medical Research, and Other Foundation Programs. The Medical Research Program is the most technology-focused, comprising the Tau Consortium (collaborative research network), the Rainwater Prize (award program), the Tauopathy Challenge Workshop (funding initiative), and the Sprint to Lead Drug Discovery Grant. RCF also provides research infrastructure including the Tau Consortium Bioinformatics Hub and Human iPSC Line Collection for the scientific community. The Foundation does not operate as a unified software platform but rather as a collection of grant-making programs and research resources.

Differentiator

Problem solved

Functional benefit

Brands

  • Tau Consortium: A collaborative research program managed and funded by RCF that commissions world-class research and drug discovery programs to treat and prevent primary tauopathies.
  • Rainwater Prize
  • Tauopathy Challenge Workshop
  • Sprint to Lead (S2L)

Products and services

  • Tau Consortium Collaborative research program funded and managed by RCF that commissions world-class research and drug discovery programs to treat and prevent primary tauopathies. It fosters high-impact networks of scientists to better understand tauopathies and guide development of effective treatments.
  • Rainwater Prize Award program recognizing scientific progress toward new treatments for neurodegenerative diseases associated with tau protein accumulation. Includes Outstanding Innovation in Neurodegenerative Research ($400K), Innovative Early-Career Scientists ($200K), Milestone Prize for Advances in Tauopathy Research (up to $2M), and Breakthrough Prize for Effective Treatments in PSP ($2M-$10M).
  • Tauopathy Challenge Workshop A funding program established in 2023 that convenes interdisciplinary experts around a single topic to address unmet needs in primary tauopathies. Provides up to $500,000 in direct costs over two years for research grants, with up to four awards funded annually.
  • Sprint to Lead (S2L) Drug Discovery Grant Program Grant program inviting original ideas focused exclusively on accelerating the development of therapies for primary tauopathies within the hit-to-lead and lead optimization development phases of drug discovery. Awards up to $400,000 direct costs for one year.
  • Tau Consortium Bioinformatics Hub Centralized platform providing researchers with high-quality computational tools, curated multi-omics datasets, analytical pipelines, and bioinformatics training resources to advance the study of tau biology and neurodegenerative disease.
  • Tau Consortium Human iPSC Line Collection A rigorously characterized repository of induced pluripotent stem cell (iPSC) lines derived from donors with tauopathy-linked mutations as well as matched controls, hosted via the Neural Stem Cell Institute.
  • Family Economic Security Program RCF program committed to supporting North Texas families and children through quality education, upskilling, affordable housing, and childcare. Includes Early Childhood & Family Support, K-12 Education, Upskilling, and Community Asset Building funding areas.
  • Grantee Portal Online portal for grant recipients to manage their grants and reporting.
  • DASH Pass Program A card that provides free access to museums, theaters, and cultural institutions across Fort Worth for families, aiming to reduce barriers to enriching experiences for children.

Quantifiable outcome

  • 8 treatments advanced into human trials through RCF medical research support
  • +6 more outcomes

Companies that use Rainwater Charitable Foundation

Customer profile

Segments4 records

Ideal customer profiles2 records

Rainwater Charitable Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rainwater Charitable Foundation partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core and minor.

  • Aging Mind FoundationcoreStrategic or Co-development Partner · 13 August 2025Co-funding partner for the Tauopathy Challenge Workshop, contributing to $2.5 million in grants for five neurodegenerative disease research projects in 2025. The partnership aims to support novel, mechanism-focused research for primary tauopathies.
  • Alzheimer's AssociationcoreStrategic or Co-development Partner · 13 August 2025Collaborative partner in the Tauopathy Challenge Workshop, co-funding grants for neurodegenerative disease research. Also partner in The Tau Pipeline Enabling Program (T-PEP). Host of Tau Global Conference with RCF.
  • CurePSPcoreStrategic or Co-development Partner · 13 August 2025Co-funding partner for the Tauopathy Challenge Workshop and multiple joint initiatives including the Biomarker Accelerator Program, Pathway and Pipeline Grant Program, Prime of Life Brain Initiative, and PSP Genetics Consortium. Co-host of Tau Global Conference.
  • Foundation for the National Institutes of Health (FNIH)coreStrategic or Co-development PartnerPartner in the Biomarkers Consortium for Neurofilament as a Blood-Based Biomarker of Neurodegeneration in FTD.
  • The Association for Frontotemporal Degeneration (AFTD)coreStrategic or Co-development PartnerPartner in the FTD Diagnostic Biomarkers Initiative to advance diagnostic capabilities for frontotemporal degenerations.
  • FTD Disorders RegistryminorStrategic or Co-development PartnerRegistry connecting patients with clinical trials and research studies for FTD and related conditions.
  • Bluefield ProjectminorStrategic or Co-development PartnerPartner in the Neurofilament Light Surveillance Project (NSP) for neurodegenerative disease research.
  • Michael J. Fox FoundationcoreStrategic or Co-development PartnerPartner in Philanthropic Investments in PET Tracers (PIPETTE) for 4R tau and alpha-synuclein PET tracer development.
  • Health Resources in Action (HRiA)minorStrategic or Co-development PartnerPartnered with RCF to map the biorepository landscape for primary tauopathies, developing a searchable database and identifying bottlenecks in sample access.
  • Mayo Clinic FloridacoreStrategic or Co-development PartnerHome to one of the world's largest tauopathy brain banks (11,000+ samples) led by Rainwater Prize winners Drs. Dickson and Murray. Key research partner in tauopathy neuropathology.
  • O-SDA IndustriesminorStrategic or Co-development PartnerDevelopment partner for the 90-unit Maren Grove affordable housing property in South Fort Worth, where RCF provided gap financing through subordinate, concessionary debt.
  • ALLFTD (ARTFL LEFFTDS Longitudinal FTLD)coreStrategic or Co-development PartnerRCF provides access to ALLFTD biospecimens and data through its tauopathy resources page, including genomic DNA, RNA, plasma, serum, PBMCs and CSF samples.
  • NCRAD (National Centralized Repository for Alzheimer’s Disease & Related Dementias)coreStrategic or Co-development PartnerRCF provides access to NCRAD biospecimens and coordinates for researchers through its primary tauopathy resources page.
  • BioSEND (Biospecimen Exchange for Neurological Disorders)coreStrategic or Co-development PartnerRCF directs researchers to BioSEND for broader neurodegenerative disease cohorts including primary tauopathies and non-tauopathies.
  • Neural Stem Cell InstitutecoreStrategic or Co-development PartnerHosts the Tau Consortium Human iPSC Line Collection providing patient-derived stem cell lines for tauopathy research.
  • NIH NeuroBioBankminorStrategic or Co-development PartnerRCF references NIH NeuroBioBank as an example of coordinated biorepository infrastructure for post-mortem brain tissue access.
  • LISC (Local Initiatives Support Corporation)minorStrategic or Co-development PartnerCommunity development financial institution that RCF mentions as potential PRI partner for managed funds focusing on affordable housing and small business capital.
  • University of BaselcoreStrategic or Co-development PartnerHome institution of 2026 Rainwater Prize winner Dr. Marc Aurel Busche, conducting research on soluble tau species and neuronal dysfunction.
  • UK Dementia Research Institute at University College LondoncoreStrategic or Co-development PartnerAffiliated institution of 2026 Rainwater Prize winner Dr. Marc Aurel Busche, supporting research on tau-related dementia mechanisms.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Rainwater Charitable Foundation competitors and assessment

Company assessment

Broad incumbents

  • Alzheimer's Association: Largest nonprofit funder of Alzheimer's disease research and a core RCF partner in the Tauopathy Challenge Workshop and Tau Global Conference. Both organizations fund neurodegenerative research and engage with overlapping scientific and patient communities.
  • Doris Duke Charitable Foundation: Large private family foundation with significant medical research funding alongside arts, environment, and child welfare programs. Structurally similar as a multi-program family foundation with comparable scale and grantmaking approach.
  • Howard Hughes Medical Institute: Major biomedical research organization funding investigator-initiated research through HHMI investigators. Comparable as a substantial private medical research funder with research infrastructure investments and scientific talent development.

Direct peers

  • CurePSP: Nonprofit focused specifically on PSP, CBD, and other prime of life neurodegenerative diseases, co-funding multiple RCF initiatives including the Biomarker Accelerator Program and PSP Genetics Consortium. Most direct peer given overlapping focus on primary tauopathies.
  • Michael J. Fox Foundation: Leading nonprofit funder of Parkinson's disease research with an analogous venture philanthropy model, including milestone-driven grants and PET tracer development. RCF partner in the PIPETTE initiative for tau and alpha-synuclein tracers.
  • Bluefield Project: Nonprofit focused on FTD research, partnering with RCF on the Neurofilament Light Surveillance Project. Direct peer given shared focus on frontotemporal degeneration and tau-related disease research.
  • BrightFocus Foundation: Nonprofit that funds research on Alzheimer's, macular degeneration, and glaucoma through grants to investigators. Comparable grantmaking model and neurodegenerative disease focus with similar scale and approach to research funding.
  • ALS Association: Major nonprofit funder of amyotrophic lateral sclerosis research, with a similar venture philanthropy model including drug discovery funding and clinical trial support. Comparable approach to accelerating neurodegenerative disease treatments.

Emerging players

  • Hereditary Disease Foundation: Family-founded nonprofit focused on Huntington's disease and other hereditary neurodegenerative disorders. Comparable in scale, founding model (family foundation), and focus on rare neurological disease research.
  • Target ALS: Nonprofit focused on accelerating ALS drug development through collaborative funding models. Comparable venture philanthropy approach with milestone-driven grants and research consortia, though focused on a different neurodegenerative disease.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

Rainwater Charitable Foundation social profiles

Digital presence

Rainwater Charitable Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rainwater Charitable Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Rainwater Charitable Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rainwater Charitable Foundation M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rainwater Charitable Foundation

What does Rainwater Charitable Foundation do?

The Rainwater Charitable Foundation is a private family foundation that makes grants across three program areas: Medical Research (funding tauopathy and neurodegenerative disease research through the Tau Consortium, Rainwater Prize, Tauopathy Challenge Workshop, and Sprint to Lead Drug Discovery grants); Family Economic Security (supporting North Texas families through quality education, upskilling, affordable housing, and childcare); and Other Foundation Programs (Africa education initiatives and scholarships). It also operates program-related investments and a Grantee Portal for grant management.

Is Rainwater Charitable Foundation a public or private company?

Rainwater Charitable Foundation is a private company. It is classified as family owned and is currently operating.

When was Rainwater Charitable Foundation founded?

Rainwater Charitable Foundation was founded in 1991. It employs 11 to 50 people.

Where is Rainwater Charitable Foundation based?

Rainwater Charitable Foundation is headquartered in Fort Worth, United States, in the North America region.

Who are Rainwater Charitable Foundation's main competitors?

Broad incumbents on record are Alzheimer's Association, Doris Duke Charitable Foundation and Howard Hughes Medical Institute. Direct peers are CurePSP, Michael J. Fox Foundation, Bluefield Project, BrightFocus Foundation and ALS Association. Emerging players are Hereditary Disease Foundation and Target ALS.

Does Rainwater Charitable Foundation have an API?

No public API is recorded for Rainwater Charitable Foundation.

What industry is Rainwater Charitable Foundation in?

Rainwater Charitable Foundation's product category is Philanthropic Foundation. Its primary akta.pro industry code is BPAGAKAB, Community Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThree Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative DiseasesThe Rainwater Charitable Foundation announced over $1 million in grants to three researchers for one-year projects targeting tau in neurodegenerative diseases. Each researcher received $350,000 to advance preclinical drug candidates, with potential for future in vivo proof-of-concept and IND-enabling studies.NewswireThree Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative DiseasesThe Rainwater Charitable Foundation announced over $1 million in grants to three researchers for one-year projects targeting tau in neurodegenerative diseases. Each researcher received $350,000 to advance preclinical drug candidates, with projects including antisense oligonucleotides, tau degraders, and brain-penetrant small molecules. The inaugural Sprint to Lead program aims to de-risk and progress these candidates.PR NewswireThe Rainwater Charitable Foundation Announces 2026 Rainwater Prize Winners, Advancing Research in Primary Tauopathies and Neurodegenerative DiseaseThe Rainwater Charitable Foundation announced the 2026 Rainwater Prize recipients, awarding $400,000 to Mayo Clinic Florida researchers Dr. Dennis Dickson and Dr. Melissa Murray for their work managing one of the world's largest tauopathy brain banks with over 11,000 samples, and $200,000 to Dr. Marc Aurel Busche of University of Basel and the UK Dementia Research Institute for discovering the role of soluble high-molecular-weight tau species in neuronal dysfunction. The awardees will be honored at the 2026 Tau Global Conference in Washington, D.C. on May 14-15.Dallas InnovatesFort Worth's Rainwater Charitable Foundation Announces 2026 Rainwater Prize WinnersThe Rainwater Charitable Foundation announced the 2026 Rainwater Prize winners, awarding $400,000 to Dennis W. Dickson and Melissa E. Murray of Mayo Clinic Florida for their collective neuropathology research on primary tauopathies, and $200,000 to Marc Aurel Busche of University of Basel and UK Dementia Research Institute for his discoveries on tau protein mechanisms. The awards recognize contributions advancing understanding and treatment of tau-associated neurodegenerative diseases including progressive supranuclear palsy and corticobasal degeneration, conditions that currently have no disease-modifying treatments. Dickson and Murray collectively direct one of the world's largest tauopathy brain banks with over 11,000 samples, and all recipients will be honored at the 2026 Tau Global Conference in Washington, D.C.RainwatercharitablefoundationThe Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy ChalFour foundations announced $2.5 million in grants for five tauopathy research projects over two years. The grants, from the Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP, fund studies on protein aggregation and tau pathology. The 2026 workshop is open for applications through September 2, 2025.PR NewswireThe Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy ChalFour foundations announced $2.5 million in grants for five tauopathy research projects over two years. The grants, from the Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP, fund studies on protein aggregation and tau pathology. The 2026 workshop is open for applications through September 2, 2025.PspThe Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy ChalThe Rainwater Charitable Foundation, in collaboration with the Aging Mind Foundation, Alzheimer's Association, and CurePSP, announced $2.5 million in grants to fund five innovative research projects over two years through the second annual Tauopathy Challenge Workshop, focused on primary tauopathies such as Progressive Supranuclear Palsy, Corticobasal Degeneration, and Frontotemporal Dementias. Recipients include researchers from the University of Sydney, Mayo Clinic, University of Southern Mississippi, and the German Center for Neurodegenerative Diseases, each exploring different mechanisms of tau pathology and protein aggregation. The workshop has now awarded a total of $4.5 million since its inception in 2023, with the 2026 session open to researchers through September 2025.YahooCurePSP Receives $200,000 Contribution from the Rainwater Charitable Foundation in Partnership to Support Grant Program for Early-Career ScientistsCurePSP received a $200,000 contribution from the Rainwater Charitable Foundation to support its Pathway and Pipeline Grant Program for early-career scientists studying PSP, CBD, or related tauopathies. The program provides seed funding of up to $100,000, and CurePSP has funded over $20 million in research since 1997.PR NewswireNew Initiative Launched to Accelerate the Use of AI in the Fight Against Neurodegenerative DiseasesThe 10,000 Brains Project, an independent nonprofit organization, has been launched to promote the ethical use of artificial intelligence in the fight against Alzheimer's, Parkinson's, and other neurodegenerative diseases. The organization has named Patrick Brannelly as founding CEO and commissioned a research roadmap, led by the Milken Institute's Science Philanthropy Accelerator for Research Collaboration, to guide the rapid adoption of AI within neurodegeneration research. Financial support for the initiative is being provided by the Robertson Foundation and Rainwater Charitable Foundation, both of which serve on the project's steering committee.United Press InternationalNew project seeks to guide AI use in treating neurodegenerative illnessesThe Oakland-based 10,000 Brains Project, a non-profit alliance of Milken Institute, Rainwater Charitable Foundation, and Robertson Foundation, aims to accelerate and safely manage AI use in neurodegenerative disease research. It will publish a roadmap for researchers this year to guide rapid AI adoption in diagnostics and treatments.